Shares of Proteome Sciences plc (LON:PRM – Get Free Report) rose 9% during mid-day trading on Monday . The company traded as high as GBX 3.91 ($0.05) and last traded at GBX 3.35 ($0.04). Approximately 967,070 shares changed hands during mid-day trading, an increase of 496% from the average daily volume of 162,146 shares. The stock had previously closed at GBX 3.07 ($0.04).
Proteome Sciences Price Performance
The firm has a fifty day moving average of GBX 2.73 and a 200 day moving average of GBX 3.15. The stock has a market cap of £9.65 million, a price-to-earnings ratio of -327.00 and a beta of 0.07.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Articles
- Five stocks we like better than Proteome Sciences
- Roth IRA Calculator: Calculate Your Potential Returns
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- CD Calculator: Certificate of Deposit Calculator
- 2 Drone Stocks Surging from Increased Media Attention
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
